PortfolioRapha Capital Management NexImmune Receives IND Clearance for Phase 1/2 trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome
PortfolioRapha Capital Management Poseida Therapeutics Appoints Kerry Ingalls as Chief Operating Officer
PortfolioRapha Capital Management Rapha Capital Management Participates in Series B Financing for ControlRad, Inc. Led by Questa Capital